These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33878204)

  • 21. Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy.
    Berg KD; Thomsen FB; Hvarness H; Christensen IJ; Iversen P
    Scand J Urol; 2014 Aug; 48(4):356-66. PubMed ID: 24579803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial.
    Tienforti D; Sacco E; Marangi F; D'Addessi A; Racioppi M; Gulino G; Pinto F; Totaro A; D'Agostino D; Bassi P
    BJU Int; 2012 Oct; 110(7):1004-10. PubMed ID: 22332815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
    Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life.
    Westhofen T; Buchner A; Lennartz S; Rodler S; Eismann L; Aydogdu C; Askari-Motlagh D; Berg E; Feyerabend E; Kazmierczak P; Jokisch F; Becker A; Stief CG; Kretschmer A
    World J Urol; 2024 Oct; 42(1):585. PubMed ID: 39427278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.
    Colicchia M; Morlacco A; Rangel LJ; Carlson RE; Dal Moro F; Karnes RJ
    Eur Urol Focus; 2019 May; 5(3):425-432. PubMed ID: 29306730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
    Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
    Eur Urol; 2015 Mar; 67(3):432-8. PubMed ID: 24582327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?
    van den Bergh RC; de Blok W; van Muilekom E; Tillier C; Venderbos LD; van der Poel HG
    Scand J Urol; 2014 Aug; 48(4):367-73. PubMed ID: 24506062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study.
    Shin DW; Lee SH; Kim TH; Yun SJ; Nam JK; Jeon SH; Park SC; Jung SI; Park JH; Park J
    Cancer Res Treat; 2019 Apr; 51(2):556-567. PubMed ID: 30011984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
    Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
    BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy.
    Fujimura T; Igawa Y; Aizawa N; Niimi A; Yamada Y; Sugihara T; Kamei J; Sato Y; Matsunaga A; Yoshida M; Shinoda Y; Fukuhara H; Nakagawa T; Homma Y; Kume H
    Neurourol Urodyn; 2019 Apr; 38(4):1067-1075. PubMed ID: 30995359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.
    Leyh-Bannurah SR; Liakos N; Oelke M; Wagner C; Schuette A; Fangmeyer B; Zinke J; Wasiri D; Mendrek M; Witt JH
    J Urol; 2021 Aug; 206(2):308-318. PubMed ID: 33904761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in patients with low-risk prostate cancer. A comparative retrospective study: brachytherapy versus robot-assisted laparoscopic prostatectomy versus active surveillance.
    Acar C; Schoffelmeer CC; Tillier C; de Blok W; van Muilekom E; van der Poel HG
    J Endourol; 2014 Jan; 28(1):117-24. PubMed ID: 23978277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EORTC quality of life questionnaire predicts early and long-term incontinence in patients treated with robotic assisted radical prostatectomy: Analysis of a large single center cohort.
    De Nunzio C; Pastore AL; Lombardo R; Cancrini F; Carbone A; Fuschi A; Dutto L; Tubaro A; Witt JH
    Urol Oncol; 2019 Dec; 37(12):1006-1013. PubMed ID: 31326315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer.
    Chaloupka M; Stoermer L; Apfelbeck M; Buchner A; Wenter V; Stief CG; Westhofen T; Kretschmer A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
    Ten Ham RMT; Broering JM; Cooperberg MR; Carroll P; Wilson LS
    Clin Genitourin Cancer; 2020 Feb; 18(1):e21-e27. PubMed ID: 31796344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term quality of life following primary treatment in men with clinical stage T3 prostate cancer.
    Namiki S; Tochigi T; Ishidoya S; Ito A; Numata I; Arai Y
    Qual Life Res; 2011 Feb; 20(1):111-8. PubMed ID: 20680687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.